SLC1A2 and Alzheimer disease: The level of glutamate uptake, measured by D- and L-[3H] aspartate binding assay in membrane preparations from the brain midfrontal cortex, as well as the GLT-1 mRNA and protein expression levels are markedly reduced in AD brains44–46 and our unpublished data).